Shelter Pharma Introduces FitKick Pro, Enhancing Wellness Offerings

Shelter Pharma Limited has officially launched its new nutraceutical product, 'FitKick Pro', effective March 30, 2026. The product, designed to enhance endurance and focus, is now available online, including through Amazon.

This launch represents a strategic move by Shelter Pharma to strengthen its position in the expanding wellness and preventive healthcare sector. By adding 'FitKick Pro', the company aims to capture consumer demand for products supporting physical performance. Its availability on e-commerce platforms like Amazon significantly broadens market reach beyond traditional distribution, potentially attracting a wider customer base.

Shelter Pharma has a track record of diversifying its product portfolio in the nutraceutical segment. In December 2025, the company launched 'D3 CURE Capsules', following the introduction of 'Allvitamins Tablet', 'Joemega Omega-3 Capsule', and 'Hairol Hair Oil' in May 2025.

The company also secured an export order worth $18,300 in March 2026 from UAE-based First Vet Veterinary Medicines Trading LLC for veterinary products, signaling international engagement. Previously, in June 2025, Shelter Pharma announced plans to raise up to INR 38.45 crore via a preferential issue of convertible equity warrants.

The introduction of FitKick Pro expands Shelter Pharma's product line with a performance-focused nutraceutical. Its availability on online platforms enhances customer access, reinforcing the company's commitment to the growing wellness market and diversifying revenue streams away from traditional herbal and veterinary products.

However, the company faces challenges. An analysis by MoneyWorks4Me in March 2026 rated Shelter Pharma as a 'below average quality company'. The stock has also shown a 'Weak' price trend, recording a -25% return over the past year, suggesting potential market concerns.

Shelter Pharma operates in a competitive nutraceutical landscape, facing established players like Dabur India Ltd., known for its Ayurvedic and FMCG products; Himalaya Wellness, a trusted name in herbal supplements; and Patanjali Ayurved, offering a wide array of natural products. These competitors also invest heavily in wellness and preventive healthcare, creating a challenging environment for new product introductions.

As of February 2026, Shelter Pharma's market capitalization stood at approximately ₹66.64 crore. The company reported trailing twelve months revenue of $6.97 million as of September 2025.

Looking ahead, investors will be watching the sales performance and market reception of FitKick Pro. Key tracking points include Shelter Pharma's progress in exploring international markets for the new product, any future product launches or partnerships in the nutraceutical space, and the company's efforts to address its 'below average quality' rating and improve stock performance. The impact of export orders on overall revenue and profitability will also be a focus.